Acute pulmonary embolism: endovascular therapy
Author(s) -
Stephen P. Reis,
Ken Zhao,
Noor Ani Ahmad,
R. Widemon,
C Root,
Seth Toomay,
James M. Horowitz,
Akhilesh K. Sista
Publication year - 2018
Publication title -
cardiovascular diagnosis and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.83
H-Index - 22
eISSN - 2223-3660
pISSN - 2223-3652
DOI - 10.21037/cdt.2017.12.05
Subject(s) - medicine , pulmonary embolism , thrombolysis , intensive care medicine , risk stratification , disease , surgery , myocardial infarction
Pulmonary embolism (PE) is a leading cause of morbidity and mortality worldwide. PE is a complex disease with a highly variable presentation and the available treatment options for PE are expanding rapidly. Anticoagulation (AC), systemic lysis, surgery, and catheter-directed thrombolysis (CDT) play important roles in treating patients with PE. Thus, a multidisciplinary approach to diagnosis, risk stratification, and therapy is required to determine which treatment option is best for a given patient with this complex disease.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom